Country | Population examined | Author | Misuse rate |
Civilian population | |||
USA | Non-institutionalized population; aged 12 or older (data collection: 2000-2002) | Kroutil et al., 2006 [45] | 7.3 million citizens at least once ADHD-medication, of it 4,529 thousand MPH |
USA | 4,297 civilian, non-institutionalized adults; between 18-49 (data collection: 2005) | Novak et al., 2007 [46] | Lifetime prevalence: 4.20% Last-year prevalence: 0.57% |
USA | 24,409 non-institutionalized youths and adults; between 16-35 (data collection: 2003) | Wu et al., 2007 [32] | Lifetime prevalence: 10.5% men/9.6% women general stimulants, of it 78.2% men/58.4% women MPH |
“Nature” readers | |||
World-wide | 1.400 “Nature” readers from 60 countries (data collection: unknown) | Maher, 2008 [47] | Lifetime prevalence: 20% general medicaments, of it 62% MPH |